InsiderTrades

Form 4 for AVR Anteris Technologies Global Corp.

Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-16 · accession 0001104659-24-129875 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2024-12-18 2024-12-16 AVR Denaro Stephen Dir A - Grant — +7,222 7,222 New —
DMI 2024-12-18 2024-12-16 AVR Denaro Stephen Dir A - Grant $0.00 +187.0K 16.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-12-16 A A 7,222 — 7,222 I See Footnote — — (F1) Represents CHESS Depositary Interests ("CDIs") of the Issuer received in exchange for an equivalent number of ordinary shares of Anteris Technologies Ltd ("ATL") in connection with a series of reorganization transactions pursuant to which the Issuer received all of the issued and outstanding shares of ATL pursuant to a scheme of arrangement (the "Scheme") under Australian law between ATL and its shareholders under Part 5.1 of the Australian Corporations Act 2001 (Cth) (the "Corporations Act"). On December 16, 2024, the effective date of the Scheme and the closing of the Issuer's U.S. initial public offering (the "Effective Date"), the closing price of the Issuer's common stock on the Nasdaq Global Market was $5.50 per share. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the Australian Securities Exchange. (F2) Held by Citicorp Nominees Pty Ltd as custodian for Sloane Pty Ltd who is the Trustee for the Denaro Superannuation Fund, for which Mr. Denaro is a beneficiary.
2 Derivative Stock Option 2024-12-16 A A 50,000 $0.00 50,000 I See Footnote $14.64 · — to 2029-06-19 50,000 Common Stock (F9) Held by Sloane Pty Ltd as Trustee for the Denaro Family Trust. The Reporting Person serves as the director and sole shareholder of Sloane Pty Ltd, which Mr. Denaro is deemed to beneficially own. (F3) Options are issued in AUD. Exercise prices have been translated into USD using the December 15, 2024 exchange rate, which was approximately A$1.00 to $0.64. (F8) The option vests in three equal annual installments beginning on June 19, 2025, subject to the Reporting Person's continued service.
3 Derivative Stock Option 2024-12-16 A A 40,000 $0.00 40,000 I See Footnote $8.25 · — to 2027-06-13 40,000 Common Stock (F9) Held by Sloane Pty Ltd as Trustee for the Denaro Family Trust. The Reporting Person serves as the director and sole shareholder of Sloane Pty Ltd, which Mr. Denaro is deemed to beneficially own. (F3) Options are issued in AUD. Exercise prices have been translated into USD using the December 15, 2024 exchange rate, which was approximately A$1.00 to $0.64. (F6) The option vests in three equal annual installments beginning on December 31, 2022, subject to the Reporting Person's continued service.
4 Derivative Stock Option 2024-12-16 A A 80,500 $0.00 80,500 I See Footnote $15.28 · — to 2028-09-15 80,500 Common Stock (F9) Held by Sloane Pty Ltd as Trustee for the Denaro Family Trust. The Reporting Person serves as the director and sole shareholder of Sloane Pty Ltd, which Mr. Denaro is deemed to beneficially own. (F3) Options are issued in AUD. Exercise prices have been translated into USD using the December 15, 2024 exchange rate, which was approximately A$1.00 to $0.64. (F7) The option vests in three equal annual installments beginning on September 15, 2024, subject to the Reporting Person's continued service.
5 Derivative Stock Option 2024-12-16 A A 16,500 $0.00 16,500 I See Footnote $7.13 · — to 2025-03-20 16,500 Common Stock (F9) Held by Sloane Pty Ltd as Trustee for the Denaro Family Trust. The Reporting Person serves as the director and sole shareholder of Sloane Pty Ltd, which Mr. Denaro is deemed to beneficially own. (F3) Options are issued in AUD. Exercise prices have been translated into USD using the December 15, 2024 exchange rate, which was approximately A$1.00 to $0.64. (F5) The option vested in two equal installments on February 8, 2022 and June 24, 2022.